SKAP1 and neoplasm: The diameter and volume of tumors were measured every 3 days, and SKAP55 KO CD8+ CTLs (Fig6D) and ADAP KO CD8+ CTLs (Supplementary Fig S6D) suppressed tumor growth more effectively than wild-type CD8+ CTLs.